Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

290

HTML

2368

Tables (1-5)

254

Sum=2912

Jan 14, 2005 (publication date) through Feb 2, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jan 14, 2005; 11(2): 187-192
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.187

Table 3 Correlation between VEGF₁₆₅ mRNA expression in liver remnant and the outcome of patients with HCC.

Outcome	Group A (%) (n = 49)	Group B (%) (n = 11)	P
Recurrence (number; %)	14(28.6)	2(18.2)	0.039
Death¹ (number; %)	13(26.5)	1(9.1)	0.048
Recurrence-free interval (median, mo)	8.5	43	0.037
Duration of survival (median, mo)	11.5	41.5	0.04

Notes: high VEGF₁₆₅ mRNA: ≥0.500 (group A), low VEGF₁₆₅ mRNA: <0.500 (group B), death1: patients died of HCC recurrence.

Citation: Sheen IS, Jeng KS, Shih SC, Kao CR, Chang WH, Wang HY, Wang PC, Wang TE, Shyung LR, Chen CZ. Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11(2): 187-192
URL: https://www.wjgnet.com/1007-9327/full/v11/i2/187.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i2.187